Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This is a study designed to evaluate the efficacy, safety, and tolerability of RGH-188
monotherapy in the treatment of acute mania. This study will be 5 weeks in duration; 3 weeks
double-blind treatment and 2-weeks safety follow-up. All patients meeting the eligibility
criteria will be randomized to one of two treatment groups: RGH-188 or placebo